Target |
Mechanism caspase inhibitors |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism caspase inhibitors |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism caspase 3 inhibitors |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date01 Jul 2004 |
Sponsor / Collaborator |
Start Date01 Nov 2003 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
IDN-5370 ( CASP ) | Nervous System Diseases More | Discontinued |
IDN-6734 ( CASP ) | Stroke More | Discontinued |
IDN-1965 ( caspase 3 ) | Heart Failure More | Discontinued |